Cargando…
Higher hydrocortisone dose increases bilirubin in hypopituitary patients‐ results from an RCT
BACKGROUND: Bilirubin has anti‐oxidative and anti‐inflammatory properties, which may explain its proposed protective effects on the development of cardiometabolic disorders. Glucocorticoids affect heme oxygenase regulation in vitro, which plays a key role in bilirubin production. Effects of variatio...
Autores principales: | Werumeus Buning, Jorien, Kootstra‐Ros, Jenny E., Brummelman, Pauline, van den Berg, Gerrit, van der Klauw, Melanie, Wolffenbuttel, Bruce H. R., van Beek, André P., Dullaart, Robin P. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111743/ https://www.ncbi.nlm.nih.gov/pubmed/26999644 http://dx.doi.org/10.1111/eci.12624 |
Ejemplares similares
-
Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone—Results from a randomized controlled trial
por: Werumeus Buning, Jorien, et al.
Publicado: (2017) -
Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study
por: Child, Christopher J, et al.
Publicado: (2011) -
Circulating Levels of Irisin in Hypopituitary and Normal Subjects
por: Pena-Bello, Lara, et al.
Publicado: (2016) -
Intestinal immunity in hypopituitary dwarf mice: effects of age
por: Wang, Xin, et al.
Publicado: (2018) -
Pharmacokinetic Modeling of Hydrocortisone by Including Protein Binding to Corticosteroid-Binding Globulin
por: Rozenveld, Eric, et al.
Publicado: (2022)